Mogalizumab-induced granulomatous eruption of the scalp: a distinct entity associated with clinical response?

Anne Pham-Ledard; Alize Pacaud; Emilie Criquet; Anne Durlach; Sarah Menguy; Marie Beylot-Barry; Florent Grange

doi:10.1016/S0959-8049(21)00717-6

Journal Articles European Journal of Cancer Year : 2021

Mogalizumab-induced granulomatous eruption of the scalp: a distinct entity associated with clinical response?

, , , (1) , , ,

1

Anne Pham-Ledard

Function : Author

Alize Pacaud

Function : Author

Emilie Criquet

Function : Author

Anne Durlach

Function : Author

Centre Hospitalier Universitaire de Reims

Sarah Menguy

Function : Author

Marie Beylot-Barry

Function : Author
PersonId : 762790
ORCID : 0000-0001-6150-1229
IdRef : 05956427X

Florent Grange

Function : Author

Domains

Life Sciences [q-bio]

valerian dormoy : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03405149

Submitted on : Wednesday, October 27, 2021-9:42:55 AM

Last modification on : Wednesday, October 27, 2021-9:43:26 AM

Dates and versions

hal-03405149 , version 1 (27-10-2021)

Identifiers

HAL Id : hal-03405149 , version 1
DOI : 10.1016/S0959-8049(21)00717-6

Cite

Anne Pham-Ledard, Alize Pacaud, Emilie Criquet, Anne Durlach, Sarah Menguy, et al.. Mogalizumab-induced granulomatous eruption of the scalp: a distinct entity associated with clinical response?. European Journal of Cancer, 2021, 156, pp.S49-S50. ⟨10.1016/S0959-8049(21)00717-6⟩. ⟨hal-03405149⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

URCA P3CELL

9 View

0 Download

Mogalizumab-induced granulomatous eruption of the scalp: a distinct entity associated with clinical response?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share